JP2019537588A5 - - Google Patents
Info
- Publication number
- JP2019537588A5 JP2019537588A5 JP2019522962A JP2019522962A JP2019537588A5 JP 2019537588 A5 JP2019537588 A5 JP 2019537588A5 JP 2019522962 A JP2019522962 A JP 2019522962A JP 2019522962 A JP2019522962 A JP 2019522962A JP 2019537588 A5 JP2019537588 A5 JP 2019537588A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- independently selected
- phenyl
- hydroxy
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610970314.3 | 2016-10-28 | ||
| CN201610970314 | 2016-10-28 | ||
| CN201710044000.5 | 2017-01-21 | ||
| CN201710044000 | 2017-01-21 | ||
| PCT/CN2017/108100 WO2018077246A1 (zh) | 2016-10-28 | 2017-10-27 | 用作神经营养因子酪氨酸激酶受体抑制剂的氨基吡唑并嘧啶化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019537588A JP2019537588A (ja) | 2019-12-26 |
| JP2019537588A5 true JP2019537588A5 (enExample) | 2022-01-21 |
| JP7046940B2 JP7046940B2 (ja) | 2022-04-04 |
Family
ID=62024344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019522962A Active JP7046940B2 (ja) | 2016-10-28 | 2017-10-27 | 神経栄養因子チロシンキナーゼ受容体阻害剤として用いられるアミノピラゾロピリミジン化合物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10829492B2 (enExample) |
| EP (1) | EP3533796B1 (enExample) |
| JP (1) | JP7046940B2 (enExample) |
| KR (1) | KR102616249B1 (enExample) |
| CN (1) | CN109890820B (enExample) |
| AU (1) | AU2017348826B2 (enExample) |
| CA (1) | CA3041942C (enExample) |
| DK (1) | DK3533796T3 (enExample) |
| ES (1) | ES2896943T3 (enExample) |
| HU (1) | HUE057733T2 (enExample) |
| MX (1) | MX380283B (enExample) |
| PL (1) | PL3533796T3 (enExample) |
| PT (1) | PT3533796T (enExample) |
| RU (1) | RU2764523C2 (enExample) |
| WO (1) | WO2018077246A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111182903A (zh) * | 2017-07-28 | 2020-05-19 | 特普医药公司 | 巨环化合物及其用途 |
| CA3071032A1 (en) * | 2017-08-23 | 2019-02-28 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Macrocycle containing aminopyrazole and pyrimidine and pharmaceutical composition and use thereof |
| CN108794370A (zh) * | 2018-07-31 | 2018-11-13 | 上海弈柯莱生物医药科技有限公司 | 一种拉罗替尼中间体的制备方法 |
| AU2019394520A1 (en) * | 2018-12-07 | 2021-07-01 | Betta Pharmaceuticals Co., Ltd | Tyrosine kinase inhibitors, compositions and methods there of |
| US20220177477A1 (en) | 2019-03-19 | 2022-06-09 | Central China Normal University | Pyrazolopyrimidine compound, pharmaceutical composition, and application therefor |
| CN112979654B (zh) * | 2019-12-16 | 2024-03-19 | 赛诺哈勃药业（成都）有限公司 | 杂芳基稠环化合物、其制备方法及应用 |
| WO2021249450A1 (zh) * | 2020-06-11 | 2021-12-16 | 贝达药业股份有限公司 | 酪氨酸激酶抑制剂的盐型、晶型、药物组合物及其用途 |
| CN111620881B (zh) * | 2020-07-08 | 2023-03-31 | 浙江合聚生物医药有限公司 | 拉罗替尼衍生物及其制备方法和应用 |
| CN113563343B (zh) * | 2020-07-27 | 2022-05-24 | 杭州邦顺制药有限公司 | 取代的吡唑并[1,5-a]嘧啶化合物及其用途 |
| CN112010860B (zh) * | 2020-08-05 | 2023-03-10 | 南京纳丁菲医药科技有限公司 | 苄氧基吡唑并嘧啶化合物和药物组合物及其应用 |
| CN114437075B (zh) * | 2020-11-03 | 2026-01-30 | 上海瑶琪生物科技有限公司 | 用作ntrk激酶抑制剂的化合物及其应用 |
| CN113200963A (zh) * | 2021-03-31 | 2021-08-03 | 广东石油化工学院 | N-(吡咯基)-3-吡唑基胺及其制备方法 |
| JP7840066B2 (ja) | 2021-05-03 | 2026-04-03 | ジェービーケーラボ カンパニー リミテッド | ２，６－ジクロロ－４－（４－（４－ヒドロキシシクロヘキシルアミノ）－７ｈ－ピロロ［２，３－ｄ］ピリミジン－５－イル）フェノールを活性成分として含有する、がんを予防、緩和、または処置するための医薬組成物 |
| WO2023006057A1 (zh) * | 2021-07-30 | 2023-02-02 | 正大天晴药业集团股份有限公司 | 氨基吡唑并嘧啶化合物的晶体 |
| CN117597129A (zh) * | 2021-08-06 | 2024-02-23 | 正大天晴药业集团股份有限公司 | 氨基吡唑并嘧啶化合物在治疗trk激酶介导的肿瘤中的用途 |
| CN117088800B (zh) * | 2023-08-18 | 2024-05-28 | 龙曦宁（上海）医药科技有限公司 | 一种5-甲基吡咯烷-3-醇盐酸盐的制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10356579A1 (de) * | 2003-12-04 | 2005-07-07 | Merck Patent Gmbh | Aminderivate |
| KR101324804B1 (ko) | 2008-05-13 | 2013-11-01 | 아이알엠 엘엘씨 | 키나제 억제제로서의 질소 함유 융합 헤테로사이클 및 그의 조성물 |
| US8841462B2 (en) | 2008-07-01 | 2014-09-23 | Robert A. Heald | Bicyclic heterocycles as MEK kinase inhibitors |
| WO2010033941A1 (en) | 2008-09-22 | 2010-03-25 | Array Biopharma Inc. | Substituted imidazo[1,2b]pyridazine compounds as trk kinase inhibitors |
| MY169791A (en) | 2008-10-22 | 2019-05-15 | Array Biopharma Inc | Substituted pyrazolo [1,5-a] pyrimidine compounds as trk kinase inhibitors |
| AR077468A1 (es) | 2009-07-09 | 2011-08-31 | Array Biopharma Inc | Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa |
| WO2012034095A1 (en) * | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
| MA34969B1 (fr) | 2011-02-25 | 2014-03-01 | Irm Llc | Composes et compositions en tant qu inibiteurs de trk |
| WO2013028263A1 (en) | 2011-08-24 | 2013-02-28 | Glaxosmithkline Llc | Pyrazolopyrimidine derivatives as pi3 kinase inhibitors |
| AU2012351748B2 (en) * | 2011-12-12 | 2016-04-14 | Dr. Reddy's Laboratories Ltd. | Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors |
| AU2014219855B2 (en) | 2013-02-19 | 2017-09-28 | Ono Pharmaceutical Co., Ltd. | Trk-inhibiting compound |
| EP2970288A1 (en) | 2013-03-15 | 2016-01-20 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| CN104650092B (zh) * | 2013-11-16 | 2017-11-10 | 广东东阳光药业有限公司 | 取代的杂芳基化合物及其组合物和用途 |
| PT3077397T (pt) * | 2013-12-06 | 2020-01-22 | Vertex Pharma | Composto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]pirazolo[1,5-a]pirimidin-3-carboxamida útil como inibidor da atr quinase, a sua preparação, diferentes formas sólidas e derivados radiomarcados do mesmo |
| CA2971024C (en) * | 2014-12-15 | 2023-09-26 | Handok Inc. | Fused ring heteroaryl compounds and their use as trk inhibitors |
-
2017
- 2017-10-27 ES ES17863410T patent/ES2896943T3/es active Active
- 2017-10-27 PL PL17863410T patent/PL3533796T3/pl unknown
- 2017-10-27 CN CN201780064022.6A patent/CN109890820B/zh active Active
- 2017-10-27 RU RU2019114600A patent/RU2764523C2/ru active
- 2017-10-27 HU HUE17863410A patent/HUE057733T2/hu unknown
- 2017-10-27 KR KR1020197015241A patent/KR102616249B1/ko active Active
- 2017-10-27 DK DK17863410.1T patent/DK3533796T3/da active
- 2017-10-27 CA CA3041942A patent/CA3041942C/en active Active
- 2017-10-27 US US16/345,679 patent/US10829492B2/en active Active
- 2017-10-27 PT PT178634101T patent/PT3533796T/pt unknown
- 2017-10-27 MX MX2019004847A patent/MX380283B/es unknown
- 2017-10-27 JP JP2019522962A patent/JP7046940B2/ja active Active
- 2017-10-27 EP EP17863410.1A patent/EP3533796B1/en active Active
- 2017-10-27 AU AU2017348826A patent/AU2017348826B2/en active Active
- 2017-10-27 WO PCT/CN2017/108100 patent/WO2018077246A1/zh not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019537588A5 (enExample) | ||
| RU2019114600A (ru) | Соединение аминопиразолопиримидина, используемое в качестве ингибитора тирозинкиназного рецептора нейротрофического фактора | |
| JP2009542721A5 (enExample) | ||
| JP2015529192A5 (enExample) | ||
| AR040230A1 (es) | Indol, azaindol, y heterociclos relacionados de 4-alquenil piperidina | |
| JP2013528204A5 (enExample) | ||
| AR104963A1 (es) | Derivados de 2-(pirazolopiridin-3-il)pirimidina como inhibidores de jak | |
| JP2024532768A5 (enExample) | ||
| CN114555588A (zh) | 作为axl抑制剂的喹唑啉类化合物 | |
| JP2016503009A5 (enExample) | ||
| JP2014505037A5 (enExample) | ||
| HRP20220414T1 (hr) | Inhibitori lizin specifične demetilaze-1 | |
| JP2016517878A5 (enExample) | ||
| JP2020510670A5 (enExample) | ||
| JP2019519586A5 (enExample) | ||
| JP2017525737A5 (enExample) | ||
| JP2009542723A5 (enExample) | ||
| JP2013501720A5 (enExample) | ||
| DK2464356T3 (en) | Sigma ligands for the prevention or treatment of pain induced by chemotherapy | |
| HRP20140953T1 (hr) | Morfolino pirimidini i njihova uporaba za lijeäśenje | |
| JP2014516074A5 (enExample) | ||
| JP2014511869A5 (enExample) | ||
| EA201070871A1 (ru) | Бициклические производные азабициклических карбоксамидов, их получение и их применение в терапии | |
| HRP20141093T1 (hr) | Triazolopirimidini | |
| RU2013147744A (ru) | Дозированная лекарственная форма для перорального применения |